Brief: Ginkgo Bioworks Holdings Inc - Selected By Pnnl To Deliver A Modular, High‑Throughput Phenotyping Platform For Doe's M2pc
05/12/2025 13:37
Dec 5 (Reuters) - Ginkgo Bioworks Holdings Inc DNA.N: GINKGO BIOWORKS HOLDINGS INC - SELECTED BY PNNL TO DELIVER A MODULAR, HIGH‑THROUGHPUT PHENOTYPING PLATFORM FOR DOE'S M2PC GINKGO BIOWORKS HOLDINGS INC - AWARDED BY ENVIRONMENTAL MOLECULAR SCIENCES LABORATORY A FOUR-YEAR, UP TO $47M CONTRACT Source text: ID:nPn9r7FxXa Further company coverage: DNA.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ginkgo Bioworks Holdings
See all newsUS STOCKS ON THE MOVE-NiSource, Hewlett Packard, Sandisk
US STOCKS ON THE MOVE-CoreWeave, Moderna, Fox Corp
Brief: Ginkgo Bioworks To Provide Autonomous Lab Access To Nsf X-Labs Researchers
US weighs allowing most pharma licensing deals with China, sources say
Ginkgo Bioworks Holdings, Inc. reports results for the quarter ended June 30 - Earnings Summary